Collected from qualified healthy donors that meet baseline FDA 21 CFR 1271 requirements, industry’s first In Stock GMP Cryopreserved Leukopaks significantly decrease lead time AllCells, the industry leader in […]
Expansion of GMP capabilities to support the rapidly growing cell and gene therapy industry AllCells Alameda, CA Expands GMP Processing Capabilities AllCells, the industry leader in the procurement and customization […]
Alameda, CA – August 31, 2021. AllCells is committed to providing the best-in-class third-party services complementary to our high-quality products. Due to the increasing demand for extended donor testing, we […]
Alameda, CA – September 15, 2020. AllCells, the leading provider of primary cells supporting biomedical research and commercialization of pharmacological and cellular therapies, announced today the addition of Cryopreserved Leukopaks […]
Alameda, CA – August 13, 2020. AllCells, the leading provider of primary cells supporting biomedical research and commercialization of pharmacological and cellular therapies, announced today that it has expanded its […]
Dear Valued Customer, As part of our commitment to quality, we are continuously improving our processes, products, and logistics. To this end, we wanted to notify our Leukopak customers of […]
Dear Valued Client, Providing our customers with high quality materials to produce the next generation of cell and gene therapies while providing world-class partnership and support is at the heart […]
February 7, 2019 Walkersville, MD (USA) / Basel (CH) – Lonza and AllCells have entered into a private label partnership for the manufacture and global commercialization of an extensive range […]
May 15, 2018 ALAMEDA, Calif.–(BUSINESS WIRE)–AllCells, LLC, the leading supplier of blood-derived cells and services for immuno- and cell therapy development, announced today that it has changed its business model […]
Copyright ©
AllCells. All rights reserved.
